BC
AUXL

Broadfin Capital’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Broadfin Capital’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-300,000
Closed -$6.02M – 81
2014
Q2 		$6.02M Sell
300,000
-111,100
-27% -$2.55M 0.59% 47
2014
Q1 		$11.2M Sell
411,100
-550,000
-57% -$14.6M 1.08% 33
2013
Q4 		$19.9M Buy
961,100
+150,000
+18% +$2.83M 2.63% 14
2013
Q3 		$14.8M Buy
811,100
+11,100
+1% +$201K 2.62% 15
2013
Q2 		$13.3M Buy
+800,000
New +$12.8M 2.6% 14

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Broadfin Capital's AUXL Position: Q3 2014 in Review

Broadfin Capital sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 300,000 shares — an estimated $6.02M sold.

Broadfin Capital first reported a position in AUXL in Q2 2013 and held it in 5 quarters. The position peaked at $19.9M in Q4 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • Broadfin Capital reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Broadfin Capital sold 300,000 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $6.02M.
  • Broadfin Capital first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Broadfin Capital's AUXILIUM PHARAMCEUTICALS INC position peaked at $19.9M in Q4 2013.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Broadfin Capital's 13F filing for Q3 2014, filed 14 Nov 2014.